logo
Yes, Humans as a Species Are Headed for Disaster. I Have a Lot of Hope for What Will Come Next.

Yes, Humans as a Species Are Headed for Disaster. I Have a Lot of Hope for What Will Come Next.

Yahoo14-05-2025

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.
I've spent most of my life terrified of climate change and the apocalyptic future it seems destined to create. I was 2 years old when climate scientist James Hansen historically testified before Congress about the 'greenhouse effect,' and things haven't exactly gotten better from there. But humming just underneath my fear of inevitable disasters, rage about our leaders' decadeslong failure to act, and grief for the version of our planet that was disappearing before my eyes, there used to be a note of dark optimism. Maybe, if it gets bad enough, humans will go extinct, I thought, hopefully.
I relished the idea of human extinction not only because it seemed obvious that the Earth would be better off without us, but because we so richly deserved it. And our species does seem determined to bring this worst-case scenario upon ourselves and our fellow creatures. We know, beyond a shadow of a doubt, that we are destroying the ecosystems we live in and depend on, and all the rest besides. No place, no matter how seemingly human-free, is safe. (See: plastic bags in the Mariana Trench.) These facts do not collectively dissuade us: We're barreling toward certain catastrophe with ever-increasing speed. I quietly hoped that one day, not too far in the future, we would have to face the ultimate consequence. It seemed as if we must.
Then I spent five years writing a book about catastrophes and cataclysms over the course of human history, from the climate change–fueled collapse of Old Kingdom Egypt to the Black Death. I cover archaeology as a science journalist, and so I ran straight toward my giddy anxiety about our species' future by calling up researchers who study events like societal collapses, plagues, and earlier periods of extreme and rapid climate change. Much to my surprise—and contrary to almost every bit of apocalyptic pop culture I'd ever consumed—many of these stories contained far more cooperation and reinvention than violence and destruction. The book, out now, is called Apocalypse: How Catastrophe Transformed Our World and Can Forge New Futures. You can see that by the time I made it to working out a subtitle, I'd had to reverse my thinking. I'm now convinced that the end of things as we know them won't actually mean the end of our species at all.
Yes, the details of the apocalypses I've researched throughout history can be tragic, and sometimes horrifying. I'll never forget the seawall that was supposed to protect a village off the coast of Israel from rising seas as the glaciers of the most recent ice age melted—it's now been underwater for 7,000 years—or the way the poorest residents of the previously egalitarian city of Harappa, in Pakistan, died violent deaths as a megadrought dragged on. But, far more often, I found that apocalypses brought out people's creativity and determination. Over and over, I saw how our ancestors tore down the old boundaries, hierarchies, assumptions, and rules that made no sense in a changed and changing world, and how they built futures designed for who they wanted and needed to become to survive.
My change of heart really began, though, when researching the story of a human extinction I thought I knew well—that of Neanderthals around 40,000 years ago. The early paleoanthropologists who discovered and first studied Neanderthal bones had assumed from the start that Neanderthals were inferior to Homo sapiens in myriad ways, including and especially intelligence, and that their distinct skeletal features disqualified them from belonging to the category of human. By the time I became an archaeology writer, many of the most egregious misconceptions about Neanderthals were well on their way to being revised and corrected, in Neanderthals' favor. The specific Neanderthal skeleton that had convinced scientists our ancient cousins walked hunched over, for example, was revealed to have belonged to not just any Neanderthal, but an elderly Neanderthal man with arthritis. Not only wasn't he a representative example of the physical abilities of his species—his long life was evidence that his community had taken care of him.
The prejudice I found harder to shake, however, wasn't about Neanderthals. It was about us, Homo sapiens. Neanderthals may not have been incapable brutes, but that only made our presumed role in their extinction all the more violent and cruel: We outcompeted them, we killed them, we took over the Earth. They weren't doomed to die because of, well, stereotypically 'Neanderthal' qualities; they were smart, capable, and caring, and we were just indiscriminate killers. In a ghastly rehearsal of the horrible effects of anthropogenic climate change on other animals, our runaway success spelled their doom.
But I was wrong: The story is, at the very least, more complicated than that. It turns out that almost every person alive today carries a small portion of Neanderthal DNA in their genome. Very literally, that means that Neanderthals are our ancestors. I started thinking about the kind of relationships between our communities that implied, and what it would have taken to have them come about. The time when Neanderthals disappeared was a period of intense climate instability, and they were already suffering from small group sizes, each trapped in pockets of habitable land during cold snaps and cut off from one another. The known existence of Neanderthal–Homo sapiens babies hints that we started living and working together in a time of hardship. Not everyone, not every group, but enough that our family trees became forever entwined. Is extinction really the right word for people who were desperate, or adventurous, enough to join new communities? Is domination really the right word for the other kinds of people who, in some instances, very likely took them in?
One day, the climate change Neanderthals coped with by joining larger and more diverse human groups may well look tame compared with what's in store for us. And in the very long term, it's possible that Earth will become a place largely unlike that which any human has ever inhabited. But we won't get to a worst-case-scenario, 4-degrees-Celsius temperature jump overnight. We will experience climate change as we already are, and as Neanderthals once did—a slow creep, noticeable in the span of a decadeslong human life. Climate change is worth slowing in any way we possibly can: There will be people who will suffer, just as there were Neanderthals who didn't survive. The destruction to human life is already happening. But taking the very long, zoomed-out view, our species will adapt. I don't mean that Homo sapiens' DNA will survive by way of billionaires holed up in expensive bunkers. That adaptation, I learned, is far more likely to take place by forming new communities, new societies, and new kinds of families than it is by destroying each other in a zero-sum game.
I've come to see that expecting—or hoping for—human extinction is actually taking the easy way out. Embracing a vision of the future that counts on the worst version of ourselves, doing the worst things we can imagine, lets us off the hook of doing the hard work of dreaming up and working toward the futures we want. Apocalypse forces us to radically change. But by facing the future with optimism instead of doom, we can transform ourselves into the kinds of people—the kinds of communities—who can survive.
There is only one thing guaranteed to go extinct in the near future, whether by choice or by force, and that's the kind of society that taught me that humans are nothing but a destructive force in the first place. We live in a society beholden to the apocalyptic philosophy of endless resource extraction. If there's no tomorrow, you can take and take and take some more. The endless consumption will end, if only because there will be nothing left to consume. We have become convinced that giving that up is tantamount to extinction—or maybe it's just that we'd rather go extinct than have to give it up. But there are so many ways to be human and, as my Neanderthal ancestors taught me, so many ways to survive. I'm done fantasizing about human extinction. I'd rather spend my time here, at the beginning of the next apocalypse, imagining what it would mean to truly change.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mass. AG Andrea Joy Campbell joins 15 states in suing Trump administration over NSF cuts
Mass. AG Andrea Joy Campbell joins 15 states in suing Trump administration over NSF cuts

Yahoo

time2 days ago

  • Yahoo

Mass. AG Andrea Joy Campbell joins 15 states in suing Trump administration over NSF cuts

Massachusetts Attorney General Andrea Campbell joined 15 other states in suing the Trump administration to stop its attempts to cut National Science Foundation programs and funding. Earlier this month, the NSF announced it would be capping indirect costs at 15%, a move that mirrored funding cuts at the National Institute of Health and the Department of Energy, both of which are currently blocked by courts. The agency, which funds nonmedical scientific research, also started eliminating programs designed to increase the participation of women, minorities, and people with disabilities in STEM fields. "The NSF's mission is to promote the progress of science, advance the national health, prosperity and welfare, and secure the national defense," a spokesperson for the NSF said in a statement. "It is our priority to ensure all NSF awards aim to create opportunities for all Americans everywhere, without exclusion of any groups.' The attorneys general say that the Trump administration does not have the power to cap research funding and eliminate diversity programs, as funding for NSF, including the diversity programs, were mandated by Congress. 'Congress has adopted a clear, longstanding national policy to advance and promote 'full use of the human resources of the Nation' in STEM fields by encouraging participation of women, minorities, and persons with disabilities,' reads the lawsuit. 'Defendants do not have authority to categorically refuse to support research that comports with the Congressionally enacted policy of the United States.' The attorneys general seek a court order ruling NSF's new policies illegal and blocking them from implementation. Campbell said that the changes to NSF will hurt Massachusetts's ability to do research and could cause the US to lose its status as a global leader in STEM research. 'Massachusetts is home to world-renowned scientific research institutions that not only drive innovative solutions to our world's most pressing challenges, but also ensure our nation maintains its global, scientific leadership,' said Campbell in a press release. 'I will continue to hold the Trump Administration accountable for the unlawful attacks on STEM funding, which jeopardize Massachusetts and this entire country's public health, economy and national security.' Joining Campbell in the coalition are the attorneys general of California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maryland, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Washington, and Wisconsin. This lawsuit comes after 13 schools, including the Massachusetts Institute of Technology and Brown University, sued the Trump administration in early May over the NSF funding cuts. The universities said that the 15% cap would cause them to lose millions of dollars and the amount of future research would 'decline precipitously.' 'From developing artificial intelligence (AI) technology to creating innovative solutions to environmental and energy challenges, NSF-funded research at American universities is vital to addressing the nation's biggest challenges and maintaining the country's competitive edge,' read Campbell's press release. 'NSF's new cap would mean essential research and infrastructure would be cut, leading to critical projects being abandoned, staff laid off, and research essential to national security, public health, and economic stability ending.' This article originally appeared on Telegram & Gazette: MA AG Andrea Campbell files NSF lawsuit against Trump administration

Single gene may help explain the plague's persistence throughout human history
Single gene may help explain the plague's persistence throughout human history

Yahoo

time3 days ago

  • Yahoo

Single gene may help explain the plague's persistence throughout human history

When you buy through links on our articles, Future and its syndication partners may earn a commission. Scientists have discovered how adaptations in a single gene helped the plague survive for hundreds of years. Responsible for the deadliest pandemic in history, the bacterium that causes the plague, Yersinia pestis, has existed in varying strains from ancient times until today. Now, scientists have unearthed a genetic clue as to how the infamous disease has persisted for millennia, with devastating outbreaks smoldering across centuries. They published their findings Thursday (May 29) in the journal Science. "This is one of the first research studies to directly examine changes in an ancient pathogen, one we still see today, in an attempt to understand what drives the virulence [disease severity], persistence and/or eventual extinction of pandemics," study co-senior author Hendrik Poinar, director of the Ancient DNA Centre at McMaster University in Ontario, Canada, said in a statement. Y. pestis has been infecting humans since before recorded history began. The most common form of the disease is known as "bubonic" and most often enters the body through bites from infected fleas, although people can less commonly catch it directly from infected animals, including rats and cats. Once inside the body, the bacterium travels to the lymph nodes and replicates. As it multiplies, it triggers the formation of painful, pus-filled "buboes," for which the bubonic plague is named. The plague bacterium can also cause a blood infection, called septicemic plague, and lung infection called pneumonic plague. Related: Oregon's 1st bubonic plague case in 8 years tied to patient's pet cat The three major plague pandemics are among the deadliest outbreaks in human history. The first pandemic, the Justinian Plague (which occurred roughly between A.D. 542 and 750), slashed the population in parts of the Mediterranean to by an estimated 40% by the end of the sixth century. The second, and most infamous, outbreak of the disease was the 14th-century Black Death that ravaged Europe and the Middle East. The single deadliest pandemic in recorded history, the Black Death killed approximately 25 million people in Europe alone — between 33% and 50% of its population. A third, lesser-known global plague pandemic began in 1855 in China's Yunnan province and killed more than 12 million people in India and China alone. This pandemic was considered active until 1960, after which plague deaths dropped to lower levels. Plague epidemics continue to this day, with the Democratic Republic of the Congo, Madagascar and Peru being the most endemic countries, according to the World Health Organization. Besides the staggering death counts associated with the pathogen, what's perhaps most remarkable about Y. pestis is the longevity of its strains. Strains of the Justinian Plague bacterium took 300 years to go extinct after outbreaks were first recorded, and one of the two lineages from the Black Death re-emerged in waves for 500 years before its disappearance, while the other became the ancestor of all present-day strains. To investigate the genetic toolkit Y. pestis uses to persist for so long, researchers conducted an analysis of a plague gene known as pla across hundreds of samples collected from ancient and modern victims of the disease. The pla gene codes for an enzyme that helps Y. pestis move through the body undetected by the host's immune system. Previous studies have suggested that pla is a key factor that modulates both the lethality of a given plague strain and its ability to spark outbreaks in humans. However, one plague strain can carry a different number of pla genes than the next, and it wasn't clear how this copy number might impact their biology, the researchers noted. To investigate, they collected multiple modern strains of Y. pestis from Vietnam that had varying numbers of copies of pla inside their genomes; carrying more copies of the gene means that the bacteria can crank out more copies of the enzyme. After injecting these different plague strains into mice, they found that the strains with fewer copies of pla led to longer infections but reduced the disease's mortality rate by up to 20%. RELATED STORIES —Diagnostic dilemma: A scientist caught plague from bacteria thought to be 'noninfectious' —Could bacteria or viruses lurking in ancient Egyptian mummies unleash a plague today? —'Black death' survivors had plague-resistant genes that may boost their descendants' risk of autoimmune disease Across the ancient plague genomes they analyzed — 20 of which dated to the first plague pandemic and 94 of which were from the second — the researchers noted a pattern where the plague strains lost copies of pla over time, namely in later stages of each pandemic. Among the modern genomes, they found three strains that hint that the same pattern is unfolding today. They theorized this adaptation likely made infections less virulent, or harmful to the host's body, over time. This suggests that the evolutionary change helped the disease to keep its hosts — be they rat or human — alive for longer, thereby enabling it to spread more widely. This adaptation may have been especially necessary after populations of the plague's primary hosts, rats, were killed off en masse during outbreaks. "The reduction of pla may reflect the changing size and density of rodent and human populations," Poinar said. "It's important to remember that plague was an epidemic of [flea-ridden] rats, which were the drivers of epidemics and pandemics. Humans were accidental victims." The scientists say that further research into both ancient and contemporary plague strains could reveal more pla depletions and help them to better understand how such changes to the germ's genome have shaped its virulence through history. Nowadays, Y. pestis infections can be cured with antibiotics, though some strains have shown troubling signs of antibiotic resistance. To head off the threat of a superbug plague outbreak, scientists in the U.K. have already started developing a bubonic plague vaccine to add to stockpiles. This article is for informational purposes only and is not meant to offer medical advice.

Opinion - Plan to restructure NIH would stall science, not streamline it
Opinion - Plan to restructure NIH would stall science, not streamline it

Yahoo

time4 days ago

  • Yahoo

Opinion - Plan to restructure NIH would stall science, not streamline it

As budget negotiations heat up in Washington, the fate of the National Institutes of Health hangs in the balance. While most attention has understandably focused on proposals to slash its funding by as much as 40 percent, another, equally troubling idea is quietly gaining traction: a complete reorganization of the NIH's structure. One recent proposal by members in Congress would consolidate the NIH's 27 specialized institutes into just eight, claiming it would reduce redundancy and improve efficiency. But this plan would not streamline science — it would stall it. Merging smaller institutes into larger ones would increase bureaucracy, not reduce it. And let's be honest: When has more government bureaucracy ever led to more innovation? Reorganizing the NIH may sound like modernization in theory. In practice, it would unleash years of administrative upheaval — rewriting missions, reassigning staff, restructuring advisory councils and disrupting funding priorities. The resulting delays would slow our country's scientific engine and give major global competitors like China a chance to pull ahead in the race for leadership in biotechnology and medicine, putting both our innovation and national security at risk. America's world-leading biomedical research ecosystem depends on the NIH — industries that support more than 10 million U.S. jobs and generate more than $3 trillion in economic activity, about 11.5 percent of our GDP. Discoveries made in university labs with NIH funding are developed into life-saving treatments by private pharmaceutical and biotech companies. In fact, 99.4 percent of FDA-approved drugs are based on NIH-supported research. Everyone who has ever taken medication, from ibuprofen for a headache to immunotherapy for cancer, has benefited from this powerful public-private partnership, with the NIH at its heart. The NIH is the most successful biomedical research institution in human history, envied by countries that have spent decades trying to replicate its model. Why? Because it works. The current system of specialized institutes at the NIH has led to transformative breakthroughs in cancer therapies, heart disease treatments, infertility, brain-machine interfaces and countless others. These achievements did not happen in spite of the NIH's structure, they happened because of it. One of NIH's greatest strengths is that each institute focuses on a specific public health challenge, from cancer and aging to mental health and infectious disease. These are not bureaucratic silos; they are engines of innovation, each tailored to the unique biology of the conditions they study. Specialized research is essential because what works for treating cancer will not work for understanding the causes of autism. It's apples and oranges. Here is one example of how the proposed reorganization could harm science: Institutes that currently focus separately on neurological disorders, oral health and vision would be combined into a single 'Institute for Neuroscience and Brain Research.' No clear explanation has been given, but the reasoning seems to be purely anatomical—if it is in the head, it can be studied together. This would lump together research on Parkinson's disease, tooth development and blindness, despite their vastly different biology and treatment needs. The result won't be the best apples and oranges ever grown — it'll be fruit sludge. Why consider such a sweeping overhaul? While consolidation is often promoted as a path to efficiency and modernization, the broader implications raise serious concerns. Reducing the number of institutes would concentrate decision-making power, increasing the risk of political influence over scientific priorities. Currently, each institute director has significant autonomy in how congressionally appropriated funds are spent — a structure designed to protect research agendas from shifting political winds. Diluting this decentralization would make science more vulnerable to ideological pressure from either side of the aisle. At a time when public trust in the NIH is already strained, the proposed reform would only deepen the problem. Equally concerning, merging institutes may diminish the role of patient advocacy groups that have long supported specialized research efforts. These groups do more than lobby policymakers, they help ensure that NIH priorities remain aligned with the needs of patients. Forcing them to compete for attention within broader, less focused institutes could weaken their impact and silence the voices of the patients they represent. There is no question that the NIH must evolve to meet today's scientific and societal challenges. Many scientists agree that some reform is long overdue. With a new director now leading the NIH, there is a real opportunity to strengthen its foundation, help it respond more effectively to today's health challenges and restore public trust. But the proposed reorganization is no such reform. It is a blunt instrument — one that would weaken the very foundation of America's scientific leadership in biomedical research, with consequences that could last for generations. Cory Miller is a professor at the University of California-San Diego who has been continuously funded by the NIH for more than 20 years, served on numerous NIH grant review sessions and been involved in several NIH committees. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store